CRP and cancer: In a large study of a cohort of patients with data on inflammatory biomarkers (including CRP, ESR, and plasma viscosity), the one-year cancer incidence [95% confidence interval (CI)] was 3.53% [3.37–3.70] in patients with at least one elevated marker (n = 116,708) and 1.50% [1.43–1.58] in those with normal inflammatory markers (n = 38,868) (p < 0.001) [10].